<DOC>
	<DOCNO>NCT00047567</DOCNO>
	<brief_summary>To study safety efficacy zonisamide adjunctive therapy child adolescent bipolar I II disorder .</brief_summary>
	<brief_title>Open-label Adjunctive Zonisamide Bipolar Disorder</brief_title>
	<detailed_description />
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Zonisamide</mesh_term>
	<criteria>Bipolar I/II Average intelligence Taking least one , two mood stabilizer</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>ZONISAMIDE</keyword>
	<keyword>BIPOLAR</keyword>
</DOC>